NCT03886155View on ClinicalTrials.gov

Cardiac Amyloidosis Screening at Trigger Finger Release

CompletedOBSERVATIONAL

Enrollment

107

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

July 2, 2020

Study Completion Date

December 2, 2021

Conditions

AmyloidosisTrigger FingerTransthyretin AmyloidosisPrimary Amyloidosis of Light Chain Type

Interventions

PROCEDURE

Biopsy

During clinically-scheduled trigger finger release surgery, soft tissue will be removed from the trigger finger tenosynovium (which may include synovial sheath and subcutaneous fat tissue) and send to pathology to be analyzed with amyloid-specific staining.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors

lead

The Cleveland Clinic

OTHER

NCT03886155 - Cardiac Amyloidosis Screening at Trigger Finger Release | Biotech Hunter | Biotech Hunter